José Luis Pérez Castrillón

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients

Daniel Antonio de Luis, M. González Sagrado, R. Conde et al. · Diabetes Research and Clinical Practice · 2009 · 42 citations

Medicine, Endocrinology, Diabetology +12

Relation of phase angle tertiles with blood adipocytokines levels, insulin resistance and cardiovascular risk factors in obese women patients.

Daniel Antonio de Luis, R. Aller, E. Romero et al. · PubMed · 2010 · 40 citations

Medicine, Endocrinology, Nutritional Sciences +17

Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients.

Daniel Antonio de Luis, R. Conde, M. González Sagrado et al. · PubMed · 2010 · 38 citations

Medicine, Pharmacology, Pharmacotherapy +17

Effects of Dietary Intake and Life Style on Bone Density in Patients with Diabetes mellitus Type 2

R. Aller, José Luis Pérez Castrillón, Jorge Luis et al. · Annals of Nutrition and Metabolism · 2004 · 29 citations

Medicine, Endocrinology, Nutrition +17